INmune Bio Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
1.540
+0.060 (4.05%)
At close: May 5, 2026, 4:00 PM EDT
1.510
-0.030 (-1.95%)
After-hours: May 5, 2026, 7:09 PM EDT
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $40.94 million as of May 5, 2026. Its market cap has decreased by -75.61% in one year.
Market Cap
40.94M
Enterprise Value
17.22M
1-Year Change
-75.61%
Ranking
Category
Stock Price
$1.54
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has decreased from $77.82M to $40.94M, a decrease of -47.39%. That is a compound annual growth rate of -8.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 4, 2026 | 39.35M | -5.13% |
| Dec 31, 2025 | 41.47M | -59.95% |
| Dec 31, 2024 | 103.55M | -48.97% |
| Dec 29, 2023 | 202.92M | 78.35% |
| Dec 30, 2022 | 113.78M | -37.49% |
| Dec 31, 2021 | 182.00M | -21.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 4, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Plus Therapeutics | 41.79M |
| Atara Biotherapeutics | 41.71M |
| Mereo BioPharma Group | 41.50M |
| Lite Strategy | 41.09M |
| RenovoRx | 39.80M |
| Lixte Biotechnology Holdings | 39.15M |
| Palatin Technologies | 38.81M |
| Aligos Therapeutics | 37.68M |